InvestorsHub Logo
Followers 25
Posts 2651
Boards Moderated 0
Alias Born 04/03/2005

Re: 2business post# 255

Tuesday, 07/21/2020 6:35:17 AM

Tuesday, July 21, 2020 6:35:17 AM

Post# of 640
Tomorrow 10:40et update on products *see news* among which I’m sure will be discussed Mino-Lok

*Partnership with a leading cancer center and support from medical thought leaders.

*In a Phase 2b trial, the Mino-Lok product demonstrated a 100% efficacy rate in salvaging colonized CVCs; the Mino-Lok product had no significant adverse events compared to an 18% serious adverse event rate when infected CVCs were removed and replaced.

*FDA Fast Track with QIDP designation and patent protection until June 2024. Formulation patent protection until November 2036.

*Currently in a Phase 3 pivotal superiority trial.

$CTXR

The very first words are "how do you do" - the last..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTXR News